Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

AdaptHealth (AHCO) Depreciation and Depletion (2019 - 2026)

AdaptHealth has reported Depreciation and Depletion over the past 7 years, most recently at $92.5 million for Q4 2025.

For Q4 2025, Depreciation and Depletion rose 8.82% year-over-year to $92.5 million; the TTM value through Dec 2025 reached $361.5 million, up 5.36%, while the annual FY2025 figure was $361.6 million, 5.39% up from the prior year.
Depreciation and Depletion for Q4 2025 was $92.5 million at AdaptHealth, roughly flat from $92.6 million in the prior quarter.
Over five years, Depreciation and Depletion peaked at $92.6 million in Q3 2025 and troughed at $36.9 million in Q1 2021.
A 5-year average of $78.9 million and a median of $85.4 million in 2024 define the central range for Depreciation and Depletion.
Biggest five-year swings in Depreciation and Depletion: soared 206.4% in 2021 and later decreased 5.96% in 2023.
Year by year, Depreciation and Depletion stood at $65.0 million in 2021, then surged by 42.0% to $92.3 million in 2022, then dropped by 5.96% to $86.8 million in 2023, then fell by 2.07% to $85.0 million in 2024, then rose by 8.82% to $92.5 million in 2025.
Business Quant data shows Depreciation and Depletion for AHCO at $92.5 million in Q4 2025, $92.6 million in Q3 2025, and $87.2 million in Q2 2025.